Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.
Clinical Development Services for the Pharmaceutical Industry
Clinical trials are essential for licensing pharmaceutical products, so carrying them out requires operational excellence. Formulation development services are crucial for developing formulations and identifying
September 20, 2024